Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice

Class:Id	LiteratureReference:9851430
_displayName	FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice
_timestamp	2023-10-25 11:54:03
author	[Person:8933680] Lee, Sun-Young [Person:9851439] Meier, Roland [Person:9851425] Furuta, Saori [Person:9851409] Lenburg, Marc E [Person:9851418] Kenny, Paraic A [Person:9851431] Xu, Ren [Person:3597670] Bissell, Mina J
created	[InstanceEdit:9851438] Orlic-Milacic, Marija, 2023-10-25
journal	J Clin Invest
pages	3211-20
pubMedIdentifier	22886303
title	FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice
volume	122
year	2012
(literatureReference)	[RegulationReference:9851451] Positive regulation by 'EGFR:FAM83B,(FAM83A, FAM83D) [plasma membrane]' FAM83A antisense RNA 1 (FAM83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPKɑ signaling in lung adenocarcinoma [Summation:188441] The cytoplasmic domain of EGFR contains tyrosine, serine and... [Summation:9851411] Both recombinant and endogenous EGFR and FAM83B form a compl...
[Change default viewing format]

No pathways have been reviewed or authored by FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice (9851430)